Related Experiment Video
Updated: Apr 2, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Diabetes and postoperative cognitive dysfunction and delirium in adults: mechanisms, biomarkers, and clinical
Abdulrahman Khaled Alwesabi1, Yuhu Ma2, Boxiong Gao1
1The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China.
Abstract:
Postoperative cognitive dysfunction (POCD) and postoperative delirium (POD) are common perioperative neurocognitive disorders, particularly affecting individuals with diabetes, who show a disproportionately higher susceptibility. Diabetic patients are at higher risk due to blood sugar fluctuations, vascular changes, and inflammation that can affect brain function. This review explores how diabetes contributes to POCD and POD, the role of biomarkers in identifying those at risk, and strategies to prevent and manage these complications. A thorough analysis of current studies highlights that factors such as hyperglycemia, glycemic variability, and diabetes-related complications significantly increase the likelihood of cognitive problems after surgery. While several tools exist to assess cognition and delirium, none reliably detect early changes on their own, underscoring the need for integrated approaches that combine biomarkers and clinical assessment. Interventions like tight blood sugar control, careful perioperative monitoring, and cognitive rehabilitation may help reduce these risks. Overall, understanding the link between diabetes and postoperative cognitive complications and implementing personalized care plans are key to improving recovery and quality of life for diabetic patients. Future research should prioritize the standardization of diagnostic criteria, the clinical validation of perioperative biomarkers, and the development of targeted preventive and therapeutic strategies for patients at increased perioperative neurocognitive risk.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon

